SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000905148-20-000781
Filing Date
2020-07-08
Accepted
2020-07-08 15:54:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc20-545_sc13da.htm SC 13D/A 202563
  Complete submission text file 0000905148-20-000781.txt   204042
Mailing Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund, L.P. (Filed by) CIK: 0001504130 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91047 | Film No.: 201018340
SIC: 2834 Pharmaceutical Preparations